Dr. Reddy's Laboratories Ltd Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 crores

Dr. Reddy's Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023 as compared to Rs. 6296.8 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 1402.5 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 959.2 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 84.22 for the period ended June 30, 2023 as compared to Rs. 57.62 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹6738.4 crs	₹6296.8 crs	7.01%
Net Profit	₹1402.5 crs	₹959.2 crs	46.22%
EPS	₹84.22	₹57.62	46.16%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs.6738.4 crores during the period ended June 30, 2023 as compared to Rs.5215.4 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.1402.5 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.1187.6 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.84.22 for the period ended June 30, 2023 as compared to Rs.71.40 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹6738.4 crs	₹5215.4 crs	29.20%
Net Profit	₹1402.5 crs	₹1187.6 crs	18.10%
EPS	₹84.22	₹71.40	17.96%

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 5426.30 as compared to the previous close of Rs. 5391.75. The total number of shares traded during the day was 14945 in over 2718 trades.

The stock hit an intraday high of Rs. 5477.55 and intraday low of 5389.65. The net turnover during the day was Rs. 81135694.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories Q1FY24 ResultUpdate RDY